| Value | ₹29.99 Cr |
|---|
NSE filing, NSE: NIDAN. Summary written from the filing by ALFA Finder's alert engine.
Nidan Laboratories And Healthcare Ltd: key numbers
- Share price
- ₹13.00
- Market cap
- ₹18.07 Cr
- Revenue (annual)
- ₹25.54 Cr
- Net profit (annual)
- ₹1.51 Cr
- P/E (TTM)
- 12.0×Sector 52.0×
- Promoter holding
- 57.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nidan Laboratories And Healthcare Ltd
All →Nidan Laboratories And Healthcare Other Announcement
Nidan Laboratories and Healthcare Limited submitted a non-applicability intimation for Corporate Governance reports. The company is exempt under SEBI Regulation 15 due to its SME listing.
Nidan Laboratories And Healthcare Annual General Meeting
Nidan Laboratories and Healthcare Limited conducted its 26th Annual General Meeting on September 28, 2026. Shareholders considered agenda items including financial statement adoption and director re-appointments.
Nidan Laboratories And Healthcare Annual General Meeting
Nidan Laboratories and Healthcare Limited will hold its 26th Annual General Meeting on September 28, 2026. The company has submitted its Annual Report for FY 2025-26.
Nidan Laboratories And Healthcare Annual General Meeting
Nidan Laboratories and Healthcare Limited will convene its 26th Annual General Meeting on September 28, 2026. The board also approved book closure and e-voting schedules.
Nidan Laboratories And Healthcare Board Meeting Date
Nidan Laboratories and Healthcare Limited has scheduled a board meeting for August 20, 2026. The meeting agenda covers general business matters.
Nidan Laboratories And Healthcare Board Meeting Outcome
Nidan Laboratories approved FY26 audited financial results and re-appointed independent directors and statutory auditors. These board decisions ensure operational continuity and regulatory compliance.
Other legal & regulatory announcements
All →Indo Amines Legal & Regulatory
Indo Amines disclosed a GST search under Maharashtra GST Act Section 67, concluded October 28, 2026. No material impact on operations or financials was reported.
Delta Corp Legal & Regulatory
CGST Goa rectified GST orders reducing Delta Corp's differential demand to ₹28.99 Crore for casino-entry packages (2017-22). Company may appeal the remaining penalty within prescribed timelines.
- Value
- ₹28.99 Cr
Jammu & Kashmir Bank Legal & Regulatory
J&K Bank announces CBIC GST circular validates its FTP position, supporting quashing of two demand orders. Total GST liability at stake is ₹8,330.87 Crore.
- Value
- ₹8,331 Cr
Shera Energy Legal & Regulatory
Shera Energy disclosed an NSE advisory letter for ICDR Reg 160(f) non-compliance on delayed warrant conversion filing. No monetary penalty was levied.
Abril Paper Tech Legal & Regulatory
April Paper Tech disclosed a personal hearing on 02 Nov 2026 on a GST show-cause notice alleging short tax payment. The company considers the demand unmaintainable and expects no financial impact.
Delta Corp Legal & Regulatory
Delta Corp disclosed GST rectification orders dated October 28, 2026. They cut aggregate differential GST demand by about INR 8.12 Crore, to INR 28.99 Crore.
- Value
- ₹8.12 Cr